ADCT — ADC Therapeutics SA Balance Sheet
0.000.00%
Last trade - 00:00
- $389.54m
- $527.24m
- $69.56m
- 10
- 11
- 97
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 20-F | 20-F | 10-K | 10-K |
Standards: | IFRS | IFRS | IFRS | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 116 | 439 | 467 | 326 | 279 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.1 | 1.44 | 30.6 | 73 | 25.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 123 | 450 | 525 | 435 | 336 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.27 | 4.76 | 11.2 | 10.3 | 16.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 138 | 514 | 618 | 491 | 355 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19.9 | 40.4 | 73.9 | 81.9 | 67.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 26.5 | 178 | 452 | 411 | 503 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 111 | 336 | 166 | 79.5 | -148 |
Total Liabilities & Shareholders' Equity | 138 | 514 | 618 | 491 | 355 |
Total Common Shares Outstanding |